Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study

Egyptian Journal of Medical Human Genetics

Table 5 Hematological parameters in AML and ALL patients and control group

	Control (n = 40)	AML (n = 40)	ALL (n = 40)	Test of sig.	p
WBCs (× 10³/μl)
Range	3.20–10.0	0.54–130.0	1.0–170.0	H = 16.452*	<0.001*
Mean ± SE	6.01 ± 0.45	35.88 ± 7.0	56.76 ± 10.25
Median	5.60	19.00	51.50
Sig. bet. grps	p₁ = 0.014, p₂ < 0.001, p₃ = 0.054
PLTs (× 10³/μl)
Range	136.0–300.0	6.0–296.0	7.0–334.0	H = 35.230*	< 0.001*
Mean ± SE	229.10 ± 12.04	65.11 ± 10.66	66.52 ± 16.12
Median	228.50	50.00	54.00
Sig. bet. grps	p₁ < 0.001, p₂ < 0.001, p₃ = 0.945
Hb (g/dl)
Range	9.80–14.0	5.50–12.20	4.50–12.70	F = 26.230*	< 0.001*
Mean ± SE	11.90 ± 0.29	8.76 ± 0.28	8.52 ± 0.50
Median	12.25	9.00	8.50
Sig. bet. grps	p₁ < 0.001, p₂ < 0.001, p₃ = 0.929

H, p: H and p values for Kruskal-Wallis test. Pairwise comparison bet. each of the 2 groups was done using post hoc test (Dunn's for multiple comparisons test). F, p, F and p values for ANOVA test. Pairwise comparison bet. each of the 2 groups was done using post hoc test (LSD). p₁, p value for comparing between control group and AML group; p₂, p value for comparing between control group and ALL group; and p₃, p value for comparing between AML group and ALL group
*Statistically significant at p ≤ 0.05